Literature DB >> 27528712

Germ line mutations in shelterin complex genes are associated with familial chronic lymphocytic leukemia.

Helen E Speedy1, Ben Kinnersley1, Daniel Chubb1, Peter Broderick1, Philip J Law1, Kevin Litchfield1, Sandrine Jayne2, Martin J S Dyer2, Claire Dearden3, George A Follows4, Daniel Catovsky5, Richard S Houlston1,5.   

Abstract

Chronic lymphocytic leukemia (CLL) can be familial; however, thus far no rare germ line disruptive alleles for CLL have been identified. We performed whole-exome sequencing of 66 CLL families, identifying 4 families where loss-of-function mutations in protection of telomeres 1 (POT1) co-segregated with CLL. The p.Tyr36Cys mutation is predicted to disrupt the interaction between POT1 and the telomeric overhang. The c.1164-1G>A splice-site, p.Gln358SerfsTer13 frameshift, and p.Gln376Arg missense mutations are likely to impact the interaction between POT1 and adrenocortical dysplasia homolog (ACD), which is a part of the telomere-capping shelterin complex. We also identified mutations in ACD (c.752-2A>C) and another shelterin component, telomeric repeat binding factor 2, interacting protein (p.Ala104Pro and p.Arg133Gln), in 3 CLL families. In a complementary analysis of 1083 cases and 5854 controls, the POT1 p.Gln376Arg variant, which has a global minor allele frequency of 0.0005, conferred a 3.61-fold increased risk of CLL (P = .009). This study further highlights telomere dysregulation as a key process in CLL development.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27528712      PMCID: PMC5271173          DOI: 10.1182/blood-2016-01-695692

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  58 in total

1.  T-Coffee: A novel method for fast and accurate multiple sequence alignment.

Authors:  C Notredame; D G Higgins; J Heringa
Journal:  J Mol Biol       Date:  2000-09-08       Impact factor: 5.469

2.  Elevated risk of chronic lymphocytic leukemia and other indolent non-Hodgkin's lymphomas among relatives of patients with chronic lymphocytic leukemia.

Authors:  Lynn R Goldin; Magnus Björkholm; Sigurdur Y Kristinsson; Ingemar Turesson; Ola Landgren
Journal:  Haematologica       Date:  2009-03-13       Impact factor: 9.941

3.  A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia.

Authors:  Maria Chiara Di Bernardo; Dalemari Crowther-Swanepoel; Peter Broderick; Emily Webb; Gabrielle Sellick; Ruth Wild; Kate Sullivan; Jayaram Vijayakrishnan; Yufei Wang; Alan M Pittman; Nicola J Sunter; Andrew G Hall; Martin J S Dyer; Estella Matutes; Claire Dearden; Tryfonia Mainou-Fowler; Graham H Jackson; Geoffrey Summerfield; Robert J Harris; Andrew R Pettitt; Peter Hillmen; David J Allsup; James R Bailey; Guy Pratt; Chris Pepper; Chris Fegan; James M Allan; Daniel Catovsky; Richard S Houlston
Journal:  Nat Genet       Date:  2008-08-31       Impact factor: 38.330

4.  Jalview Version 2--a multiple sequence alignment editor and analysis workbench.

Authors:  Andrew M Waterhouse; James B Procter; David M A Martin; Michèle Clamp; Geoffrey J Barton
Journal:  Bioinformatics       Date:  2009-01-16       Impact factor: 6.937

5.  Maximum entropy modeling of short sequence motifs with applications to RNA splicing signals.

Authors:  Gene Yeo; Christopher B Burge
Journal:  J Comput Biol       Date:  2004       Impact factor: 1.479

6.  The POT1-TPP1 telomere complex is a telomerase processivity factor.

Authors:  Feng Wang; Elaine R Podell; Arthur J Zaug; Yuting Yang; Paul Baciu; Thomas R Cech; Ming Lei
Journal:  Nature       Date:  2007-01-21       Impact factor: 69.504

7.  A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk.

Authors:  Karen A Pooley; Stig E Bojesen; Maren Weischer; Sune F Nielsen; Deborah Thompson; Ali Amin Al Olama; Kyriaki Michailidou; Jonathan P Tyrer; Sara Benlloch; Judith Brown; Tina Audley; Robert Luben; K-T Khaw; David E Neal; Freddie C Hamdy; Jenny L Donovan; Zsofia Kote-Jarai; Caroline Baynes; Mitul Shah; Manjeet K Bolla; Qin Wang; Joe Dennis; Ed Dicks; Rongxi Yang; Anja Rudolph; Joellen Schildkraut; Jenny Chang-Claude; Barbara Burwinkel; Georgia Chenevix-Trench; Paul D P Pharoah; Andrew Berchuck; Rosalind A Eeles; Douglas F Easton; Alison M Dunning; Børge G Nordestgaard
Journal:  Hum Mol Genet       Date:  2013-07-29       Impact factor: 6.150

8.  Nonsense mutations in the shelterin complex genes ACD and TERF2IP in familial melanoma.

Authors:  Lauren G Aoude; Antonia L Pritchard; Carla Daniela Robles-Espinoza; Karin Wadt; Mark Harland; Jiyeon Choi; Michael Gartside; Víctor Quesada; Peter Johansson; Jane M Palmer; Andrew J Ramsay; Xijun Zhang; Kristine Jones; Judith Symmons; Elizabeth A Holland; Helen Schmid; Vanessa Bonazzi; Susan Woods; Ken Dutton-Regester; Mitchell S Stark; Helen Snowden; Remco van Doorn; Grant W Montgomery; Nicholas G Martin; Thomas M Keane; Carlos López-Otín; Anne-Marie Gerdes; Håkan Olsson; Christian Ingvar; Ake Borg; Nelleke A Gruis; Jeffrey M Trent; Göran Jönsson; D Timothy Bishop; Graham J Mann; Julia A Newton-Bishop; Kevin M Brown; David J Adams; Nicholas K Hayward
Journal:  J Natl Cancer Inst       Date:  2014-12-13       Impact factor: 13.506

9.  Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia.

Authors:  Sonja I Berndt; Christine F Skibola; Vijai Joseph; Nicola J Camp; Alexandra Nieters; Zhaoming Wang; Wendy Cozen; Alain Monnereau; Sophia S Wang; Rachel S Kelly; Qing Lan; Lauren R Teras; Nilanjan Chatterjee; Charles C Chung; Meredith Yeager; Angela R Brooks-Wilson; Patricia Hartge; Mark P Purdue; Brenda M Birmann; Bruce K Armstrong; Pierluigi Cocco; Yawei Zhang; Gianluca Severi; Anne Zeleniuch-Jacquotte; Charles Lawrence; Laurie Burdette; Jeffrey Yuenger; Amy Hutchinson; Kevin B Jacobs; Timothy G Call; Tait D Shanafelt; Anne J Novak; Neil E Kay; Mark Liebow; Alice H Wang; Karin E Smedby; Hans-Olov Adami; Mads Melbye; Bengt Glimelius; Ellen T Chang; Martha Glenn; Karen Curtin; Lisa A Cannon-Albright; Brandt Jones; W Ryan Diver; Brian K Link; George J Weiner; Lucia Conde; Paige M Bracci; Jacques Riby; Elizabeth A Holly; Martyn T Smith; Rebecca D Jackson; Lesley F Tinker; Yolanda Benavente; Nikolaus Becker; Paolo Boffetta; Paul Brennan; Lenka Foretova; Marc Maynadie; James McKay; Anthony Staines; Kari G Rabe; Sara J Achenbach; Celine M Vachon; Lynn R Goldin; Sara S Strom; Mark C Lanasa; Logan G Spector; Jose F Leis; Julie M Cunningham; J Brice Weinberg; Vicki A Morrison; Neil E Caporaso; Aaron D Norman; Martha S Linet; Anneclaire J De Roos; Lindsay M Morton; Richard K Severson; Elio Riboli; Paolo Vineis; Rudolph Kaaks; Dimitrios Trichopoulos; Giovanna Masala; Elisabete Weiderpass; María-Dolores Chirlaque; Roel C H Vermeulen; Ruth C Travis; Graham G Giles; Demetrius Albanes; Jarmo Virtamo; Stephanie Weinstein; Jacqueline Clavel; Tongzhang Zheng; Theodore R Holford; Kenneth Offit; Andrew Zelenetz; Robert J Klein; John J Spinelli; Kimberly A Bertrand; Francine Laden; Edward Giovannucci; Peter Kraft; Anne Kricker; Jenny Turner; Claire M Vajdic; Maria Grazia Ennas; Giovanni M Ferri; Lucia Miligi; Liming Liang; Joshua Sampson; Simon Crouch; Ju-Hyun Park; Kari E North; Angela Cox; John A Snowden; Josh Wright; Angel Carracedo; Carlos Lopez-Otin; Silvia Bea; Itziar Salaverria; David Martin-Garcia; Elias Campo; Joseph F Fraumeni; Silvia de Sanjose; Henrik Hjalgrim; James R Cerhan; Stephen J Chanock; Nathaniel Rothman; Susan L Slager
Journal:  Nat Genet       Date:  2013-06-16       Impact factor: 41.307

10.  The ICR1000 UK exome series: a resource of gene variation in an outbred population.

Authors:  Elise Ruark; Márton Münz; Anthony Renwick; Matthew Clarke; Emma Ramsay; Sandra Hanks; Shazia Mahamdallie; Anna Elliott; Sheila Seal; Ann Strydom; Lunter Gerton; Nazneen Rahman
Journal:  F1000Res       Date:  2015-09-22
View more
  38 in total

1.  Haematological cancer: Shelterin complex mutated in familial CLL.

Authors:  Peter Sidaway
Journal:  Nat Rev Clin Oncol       Date:  2016-09-20       Impact factor: 66.675

2.  Ethnic and geographic diversity of chronic lymphocytic leukaemia.

Authors:  Shenmiao Yang; Abraham M Varghese; Nitin Sood; Carlos Chiattone; Norah O Akinola; Xiaojun Huang; Robert Peter Gale
Journal:  Leukemia       Date:  2020-10-19       Impact factor: 11.528

3.  POT1 mutation spectrum in tumour types commonly diagnosed among POT1-associated hereditary cancer syndrome families.

Authors:  Erica Shen; Joanne Xiu; Giselle Y Lopez; Rex Bentley; Ali Jalali; Amy B Heimberger; Matthew N Bainbridge; Melissa L Bondy; Kyle M Walsh
Journal:  J Med Genet       Date:  2020-01-14       Impact factor: 6.318

4.  Analysis of 153 115 patients with hematological malignancies refines the spectrum of familial risk.

Authors:  Amit Sud; Subhayan Chattopadhyay; Hauke Thomsen; Kristina Sundquist; Jan Sundquist; Richard S Houlston; Kari Hemminki
Journal:  Blood       Date:  2019-08-08       Impact factor: 22.113

5.  A new POT1 germline mutation-expanding the spectrum of POT1-associated cancers.

Authors:  Tremika Le-Shan Wilson; Namita Hattangady; Antonio Marcondes Lerario; Carmen Williams; Erika Koeppe; Shane Quinonez; Jenae Osborne; Kelly B Cha; Tobias Else
Journal:  Fam Cancer       Date:  2017-10       Impact factor: 2.375

Review 6.  Germline mutations predisposing to melanoma.

Authors:  Atrin Toussi; Nicole Mans; Jeanna Welborn; Maija Kiuru
Journal:  J Cutan Pathol       Date:  2020-05-11       Impact factor: 1.587

Review 7.  A Systematic Literature Review of Whole Exome and Genome Sequencing Population Studies of Genetic Susceptibility to Cancer.

Authors:  Alisa M Goldstein; Elizabeth M Gillanders; Melissa Rotunno; Rolando Barajas; Mindy Clyne; Elise Hoover; Naoko I Simonds; Tram Kim Lam; Leah E Mechanic
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-05-28       Impact factor: 4.254

8.  POT1 germline mutations but not TERT promoter mutations are implicated in melanoma susceptibility in a large cohort of Spanish melanoma families.

Authors:  M Potrony; J A Puig-Butille; M Ribera-Sola; V Iyer; C D Robles-Espinoza; P Aguilera; C Carrera; J Malvehy; C Badenas; M T Landi; D J Adams; S Puig
Journal:  Br J Dermatol       Date:  2019-02-27       Impact factor: 9.302

Review 9.  Dysfunctional telomeres and hematological disorders.

Authors:  Elena Fiorini; Andrea Santoni; Simona Colla
Journal:  Differentiation       Date:  2018-01-04       Impact factor: 3.880

10.  Germline mutations in Protection of Telomeres 1 in two families with Hodgkin lymphoma.

Authors:  Mary L McMaster; Chongkui Sun; Maria T Landi; Sharon A Savage; Melissa Rotunno; Xiaohong R Yang; Kristine Jones; Aurélie Vogt; Amy Hutchinson; Bin Zhu; Mingyi Wang; Belynda Hicks; Anand Thirunavukarason; Douglas R Stewart; Stella Koutros; Alisa M Goldstein; Stephen J Chanock; Neil E Caporaso; Margaret A Tucker; Lynn R Goldin; Yie Liu
Journal:  Br J Haematol       Date:  2018-05       Impact factor: 6.998

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.